Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,530,767
  • Shares Outstanding, K 127,752
  • Annual Sales, $ 642,820 K
  • Annual Income, $ -43,540 K
  • EBIT $ -61 M
  • EBITDA $ -17 M
  • 60-Month Beta 2.20
  • Price/Sales 3.80
  • Price/Cash Flow N/A
  • Price/Book 2.95

Options Overview Details

View History
  • Implied Volatility 84.20% (-14.09%)
  • Historical Volatility 76.00%
  • IV Percentile 61%
  • IV Rank 43.52%
  • IV High 127.16% on 04/23/25
  • IV Low 51.09% on 08/21/25
  • Expected Move (DTE 23) 2.59 (13.09%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 811
  • Volume Avg (30-Day) 653
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 9,060
  • Open Int (30-Day) 9,371
  • Expected Range 17.22 to 22.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.25
  • Number of Estimates 8
  • High Estimate -0.07
  • Low Estimate -0.41
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +30.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.90 +24.59%
on 03/16/26
23.30 -14.98%
on 03/03/26
+0.71 (+3.72%)
since 02/24/26
3-Month
15.90 +24.59%
on 03/16/26
23.56 -15.92%
on 01/23/26
+3.12 (+18.69%)
since 12/24/25
52-Week
6.78 +192.18%
on 04/07/25
23.56 -15.92%
on 01/23/26
+9.42 (+90.66%)
since 03/24/25

Most Recent Stories

More News
3 Reasons to Sell TXG and 1 Stock to Buy Instead

3 Reasons to Sell TXG and 1 Stock to Buy Instead

TXG : 19.81 (+3.50%)
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

- Fueled by best-in-class technology and deep expertise in genome engineering and AI, PerturbAI is uniquely positioned to redefine therapeutic discovery, making it more scalable, translatable and cost-efficient...

TXG : 19.81 (+3.50%)
1 Cash-Producing Stock with Competitive Advantages and 2 We Ignore

1 Cash-Producing Stock with Competitive Advantages and 2 We Ignore

BURL : 325.15 (+2.06%)
TXG : 19.81 (+3.50%)
RCL : 273.39 (-2.00%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

TXG : 19.81 (+3.50%)
LMAT : 109.99 (+1.97%)
MRNA : 51.34 (+0.12%)
3 Russell 2000 Stocks We Approach with Caution

3 Russell 2000 Stocks We Approach with Caution

TXG : 19.81 (+3.50%)
PWP : 17.24 (-0.12%)
BKD : 13.95 (+0.43%)
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers

Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers

TXG : 19.81 (+3.50%)
3 Stocks Under $50 We’re Skeptical Of

3 Stocks Under $50 We’re Skeptical Of

TXG : 19.81 (+3.50%)
SBH : 13.81 (+0.29%)
PEGA : 41.95 (-5.43%)
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

PLEASANTON, Calif. , Feb. 19, 2026 /PRNewswire/ -- 10x Genomics, Inc.  (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate...

TXG : 19.81 (+3.50%)
5 Must-Read Analyst Questions From 10x Genomics’s Q4 Earnings Call

5 Must-Read Analyst Questions From 10x Genomics’s Q4 Earnings Call

TXG : 19.81 (+3.50%)
3 Volatile Stocks We Steer Clear Of

3 Volatile Stocks We Steer Clear Of

TXG : 19.81 (+3.50%)
ASLE : 6.26 (-0.48%)
WFC : 79.61 (+1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 21.35
2nd Resistance Point 20.62
1st Resistance Point 20.22
Last Price 19.81
1st Support Level 19.09
2nd Support Level 18.36
3rd Support Level 17.96

See More

52-Week High 23.56
Last Price 19.81
Fibonacci 61.8% 17.15
Fibonacci 50% 15.17
Fibonacci 38.2% 13.19
52-Week Low 6.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.